Global Health Approves ₹997 Crore Hospital Project in Ghaziabad, Reports Q2 FY27 Results
Global Health Limited (Medanta) approved a ₹997 crore project to build a 500-bedded hospital in Ghaziabad, Uttar Pradesh. The company also reported Q2 FY27 results, with consolidated revenue at ₹14,690.43 crore and profit after tax at ₹2,191.44 crore. The project is slated for phased addition over 3-4 years.
The substantial investment in capacity expansion and the positive financial performance are material events for the company's future growth and investor outlook.
The approval of a significant new hospital project and the reporting of positive financial results contribute to a positive sentiment.
Global Health Limited (Medanta) announced a significant capacity addition with the approval of a ₹997 crore project for a 500-bedded hospital in Ghaziabad, Uttar Pradesh. The project, to be developed on a 10560.36 sq. meter land parcel, will be funded through a mix of internal accruals and debt, with the land purchase costing ₹165.82 crore. This expansion is driven by Ghaziabad's growing population, urbanization, and its strategic location within the NCR region, aiming to address the increasing demand for advanced medical care.
In parallel, the company reported its unaudited standalone and consolidated financial results for the second quarter and half-year ended September 30, 2026. For the second quarter, consolidated revenue from operations stood at ₹14,690.43 crore, with profit after tax at ₹2,191.44 crore. For the half-year, consolidated revenue was ₹27,730.94 crore, and profit after tax was ₹3,763.96 crore. The company's Board of Directors approved these results and confirmed an unmodified audit opinion from statutory auditors M/s Walker Chandiok & Co LLP. The trading window will reopen 48 hours after the declaration of these results.
What to do with a filing like this
Global Health Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Global Health Limited. Read the original for the full detail.